|
|
||||||||
Department of Pediatrics, Harbor-UCLA Medical Center, University of California, Los Angeles, School of Medicine, Torrance, California 90509
-Adrenergic agonists are important regulators
of perinatal pulmonary circulation. They cause vasodilation primarily
via the adenyl cyclase-adenosine 3',5'-cyclic monophosphate
(cAMP) pathway. We examined the responses of isolated fourth-generation
pulmonary veins of term fetal (145 ± 2 days gestation)
and newborn (10 ± 1 days) lambs to isoproterenol, a
-adrenergic
agonist. In vessels preconstricted with U-46619 (a thromboxane
A2 analog), isoproterenol induced
greater relaxation in pulmonary veins of newborn lambs than in those of
fetal lambs. The relaxation was eliminated by propranolol, a
-adrenergic antagonist. Forskolin, an activator of adenyl cyclase,
also caused greater relaxation of veins of newborn than those of fetal
lambs. 8-Bromoadenosine 3',5'-cyclic monophosphate, a cell
membrane-permeable analog of cAMP, induced a similar relaxation of all
vessels. Biochemical studies show that isoproterenol and forskolin
induced a greater increase in cAMP content and in adenyl cyclase
activity of pulmonary veins in the newborn than in the fetal lamb.
These results demonstrate that
-adrenergic-agonist-mediated
relaxation of pulmonary veins increases with maturation. An increase in
the activity of adenyl cyclase may contribute to the change.
-adrenergic agonist; adenyl cyclase; vascular smooth muscle; neonatal pulmonary circulation
This article has been cited by other articles:
![]() |
X. Ding and P. A. Murray Cellular mechanisms of thromboxane A2-mediated contraction in pulmonary veins Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L825 - L833. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guimaraes and D. Moura Vascular Adrenoceptors: An Update Pharmacol. Rev., June 1, 2001; 53(2): 319 - 356. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |